Home
Live
News
Create
Screeners
Insights
Akums Drugs & Pharma
474.
95
+3.55
(+0.75%)
Market Cap
₹7,475.40 Cr
PE Ratio
22.72
Industry
Healthcare
Buy
Sell
Company Performance:
1D
+0.75%
1M
-0.93%
6M
-6.96%
1Y
-43.54%
5Y
-40.35%
View Company Insights
Latest news about Akums Drugs & Pharma
Akums Drugs Inks Framework Agreement with Zambia for Local Manufacturing Facility
Aug 22, 2025
Akums Drugs & Pharma signed a Framework Agreement with the Zambian government to set up a local manufacturing facility. The joint venture, with Akums holding 51% stake, aims to begin operations in 2028, producing various pharmaceutical products. Until then, Zambia will purchase medicines worth $50 million over two years from Akums' Indian facilities. The collaboration seeks to support Zambian health programs, enhance local production, and potentially export to neighboring African countries. Akums will provide technology and expertise through a separate agreement.
Akums Drugs Reports 19% EBITDA Growth in Q1, Expands European Presence
Aug 18, 2025
Akums Drugs Reports 19% YoY Growth in Adjusted EBITDA, Achieves 1,000 DCGI Approvals Milestone
Aug 08, 2025
Akums Drugs Swings to Profit in Q4, Revenue Grows
May 27, 2025
AKUMS DRUGS Achieves Remarkable Turnaround in Q4 Financial Performance
May 26, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation